Edwards Lifesciences Corp

$76.04
(as of Apr 25, 7:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Edwards Lifesciences Corp

Stock Price
$76.04
Ticker Symbol
EW
Exchange
NYSE

Industry Information for Edwards Lifesciences Corp

Sector
Healthcare
Industry
Medical Devices

Company Description for Edwards Lifesciences Corp

Country
USA
Full Time Employees
15,800

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Fundamentals for Edwards Lifesciences Corp

Market Capitalization
$44,007,772,160
EBITDA
$1,686,200,064
Dividends per Share
P/E Ratio
31.57
Forward P/E Ratio
28.99
Earnings per Share
$2.38
Earnings per Share Estimate Next Year
Profit Margin
75.71%
Shares Outstanding
585,755,008
Percent Owned by Insiders
0.90%
Percent Owned by Institutions
88.61%
52-Week High
52-Week Low

Technical Indicators for Edwards Lifesciences Corp

50-Day Moving Average
200-Day Moving Average
RSI
63.15
2.46

Analyst Ratings for Edwards Lifesciences Corp

Strong Buy
10
Buy
5
Hold
17
Sell
0
Strong Sell
1

News About Edwards Lifesciences Corp

Apr 24, 2025, 2:25 PM EST
Edwards Lifesciences recently announced its updated guidance, projecting second-quarter 2025 sales between $1.45 billion and $1.53 billion, alongside first-quarter results showing a rise in sales and net income compared to the previous year. See more.
Apr 24, 2025, 9:34 AM EST
Texas Instruments, Mondelez downgraded: Wall Street's top analyst calls See more.
Apr 24, 2025, 8:50 AM EST
Participants See more.
Apr 24, 2025, 6:43 AM EST
Edwards Lifesciences Corporation EW reported first-quarter 2025 adjusted earnings per share (EPS) of 64 cents, which surpassed the Zacks Consensus Estimate by 6.7%. See more.